MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer. - Chattopadhyay, S.; Machado-Pinilla, R.; Manguan-García, C.; Belda-Iniesta, C.; Moratilla, C.; Cejas, P.; Fresno-Vara, J. A.; de Castro-Carpeño, J.; Casado, E.; Nistal, M.; Gonzalez-Barón, M.; Perona, R. (Oncogene, 2006)